Get our Free Patent Expiration, Litigation, and Drug Price Updates

Serving hundreds of leading biopharmaceutical companies globally:

Cantor Fitzgerald
Mallinckrodt
Healthtrust
Federal Trade Commission
Medtronic
Citi

Generated: April 24, 2019

DrugPatentWatch Database Preview

Cefepime hydrochloride - Generic Drug Details

« Back to Dashboard

What are the generic sources for cefepime hydrochloride and what is the scope of cefepime hydrochloride freedom to operate?

Cefepime hydrochloride is the generic ingredient in five branded drugs marketed by B Braun, Acs Dobfar, Fosun Pharma, Hospira Inc, Qilu Pharm Co Ltd, Sagent Pharms, Baxter Hlthcare, and Samson Medcl, and is included in ten NDAs. Additional information is available in the individual branded drug profile pages.

There are twenty drug master file entries for cefepime hydrochloride. Thirteen suppliers are listed for this compound.

Pharmacology for cefepime hydrochloride
Synonyms for cefepime hydrochloride
(6R,7R)-7-[[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-3-[(1-methylpyrrolidin-1-ium-1-yl)methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid chloride hydrochloride
(6R,7R)-7-[[(2Z)-2-(2-aminothiazol-4-yl)-2-methoxyimino-acetyl]amino]-3-[(1-methylpyrrolidin-1-ium-1-yl)methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid chloride hydrate hydrochloride
1-(((6R,7R)-7-(2-(2-amino-4-thiazolyl)glyoxylamido)-2-carboxy-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-en-3- yl)methyl)-1-methylpyrrolidinium chloride, 7(2)-(Z)-(O-methyloxime) monohydrochloride monohydrate
1-(((6R,7R)-7-(2-(2-Amino-4-thiazolyl)glyoxylamido)-2-carboxy-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-en-3-yl)methyl)-1-methylpyrrolidinium chloride, 7(sup 2)-(Z)-(O-methyloxime), monohydrochloride, monohydrate
1-{[(6R,7R)-7-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-2-carboxy-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-en-3-yl]methyl}-1-methylpyrrolidinium chloride hydrochloride--water (1/1)
107648-80-6
123171-59-5
156807-40-8
2A1O4F5N0C
3533AH
647035-01-6
648C806
7beta-[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetamido]-3-[(1-methylpyrrolidinium-1-yl)methyl]-3,4-didehydrocepham-4-carboxylic acid chloride hydrochloride--water (1/1)
A-8993
AC-6021
AC1NUS5W
AK163997
AKOS015994689
AKOS016340425
AKOS024464938
AKOS030623159
AN-32784
Axepim
BC682282
BMY 28142 2HCl.H2O
BMY-28142 2HCl.H2O
BMY-28142 dihydrochloride
C12557
C19H24N6O5S2.2ClH
CAS-123171-59-5
Cefepime (Dihydrochloride Monohydrate)
Cefepime chloride hydrochloride hydrate
cefepime dihydrochloride
Cefepime dihydrochloride hydrate
Cefepime dihydrochloride hydrate (JP17)
cefepime dihydrochloride monohydrate
Cefepime HCl
CEFEPIME HYDROCHLORIDE (ARGININE FORMULATION)
Cefepime hydrochloride (USP)
Cefepime hydrochloride [USAN:USP]
Cefepime hydrochloride anhydrous
cefepime hydrochloride hydrate
Cefepime hydrochloride monohydrate
Cefepime In Plastic Container
Cefepime.HCl
Cefeprime dihydrochloride
Cepimax
Cepimex
CHEBI:31368
CHEMBL1200962
CS-2841
D01157
DS-8399
DSSTox_CID_25603
DSSTox_GSID_45603
DSSTox_RID_80996
DTXSID7045603
HY-B0616
I8X1O0607P
KS-1148
Maxcef
Maxipime (TN)
MolPort-023-298-798
MolPort-035-758-251
NCGC00017147-01
Pyrrolidinium, 1-((7-(((2-amino-4-thiazolyl)(methoxyimino)acetyl)amino)-2-carboxy-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-en-3-yl)methyl)-1-methyl-, chloride, monohydrochloride, (6R-(6alpha,7beta(Z)))-
Pyrrolidinium, 1-((7-(((2-amino-4-thiazolyl)(methoxyimino)acetyl)amino)-2-carboxy-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-en-3-yl)methyl)-1-methyl-, chloride, monohydrochloride, monohydrate, (6R-(6alpha,7beta(Z)))-
SCHEMBL2561605
SCHEMBL993564
ST24046295
Tox21_110801
UNII-2A1O4F5N0C
UNII-I8X1O0607P

US Patents and Regulatory Information for cefepime hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Hospira Inc MAXIPIME cefepime hydrochloride INJECTABLE;INJECTION 050679-002 Jan 18, 1996 AP RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Hospira Inc CEFEPIME HYDROCHLORIDE cefepime hydrochloride INJECTABLE;INJECTION 065369-003 Jun 18, 2007 AP RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Qilu Pharm Co Ltd CEFEPIME HYDROCHLORIDE cefepime hydrochloride INJECTABLE;INJECTION 203704-003 Feb 1, 2016 AP RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Hospira Inc CEFEPIME HYDROCHLORIDE cefepime hydrochloride INJECTABLE;INJECTION 065369-002 Jun 18, 2007 AP RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Qilu Pharm Co Ltd CEFEPIME HYDROCHLORIDE cefepime hydrochloride INJECTABLE;INJECTION 203704-002 Feb 1, 2016 AP RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Hospira Inc CEFEPIME HYDROCHLORIDE cefepime hydrochloride INJECTABLE;INJECTION 202268-001 Jul 30, 2012 AP RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Army
Johnson and Johnson
Merck
Accenture
Queensland Health
Julphar

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.